European Journal of Epidemiology

, Volume 24, Issue 8, pp 393–395 | Cite as

Recent and future developments in the epidemiology of the infectious diseases

  • Didier Raoult

Microbiology, that is the unseen living world, is only known very superficially but our knowledge is growing rapidly. This is exemplified by metagenomic studies where all nucleic acids are sequenced from the environment, showing that 70% of sequences obtained from the environment have no match with any database (Eukaryotes, Bacteria, viruses or Archae) [1]. This is measuring objectively our level of ignorance. Therefore understanding now completely human diseases is impossible because of this gap of knowledge of the potential infectious hazards of our environment. This gap of knowledge can result in overinterpretation of currently known factors, if our ignorance is not acknowledged. As a result, conclusions based on statistical tendencies inducted from our current knowledge, will be indeed challenged in the future. Recently new tools such as 16S rDNA amplification and sequencing has allowed the discovery and identification of hundreds of new bacterial pathogens in the 10 last years [2]...


Gastric Cancer Cervical Cancer Human Papilloma Virus Gastroenteritis Nobel Prize 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Raoult D, Forterre P. Redefining viruses: lessons from Mimivirus. Nat Rev Microbiol. 2008;6:315–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45:2761–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Enserink M. Global health. Some neglected diseases are more neglected than others. Science. 2009;323:700.PubMedCrossRefGoogle Scholar
  5. 5.
    Raoult D, Fournier PE, Drancourt M. What does the future hold for clinical microbiology? Nat Rev Microbiol. 2004;2:151–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol. 2008;42:233–43.PubMedCrossRefGoogle Scholar
  7. 7.
    Kahn JS. Newly identified respiratory viruses. Pediatr Infect Dis J. 2007;26:745–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis. 2008;47:1202–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Protano C, Vitali M, Raitano A, Sancin A, Agolini G. Is there still space for the implementation of antisepsis and disinfection to prevent rotavirus and norovirus gastroenteritis outbreaks? J Prev Med Hyg. 2008;49:55–60.PubMedGoogle Scholar
  10. 10.
    Gouriet F, Levy PY, Samson L, Drancourt M, Raoult D. Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial pneumonia. Clin Microbiol Infect. 2008;14:1119–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Pincock S. Nobel Prize winners Robin Warren and Barry Marshall. Lancet. 2005;366:1429.PubMedCrossRefGoogle Scholar
  12. 12.
    Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Pincock S. Virologist wins Nobel for cervical cancer discovery. Lancet. 2008;372:1374.PubMedCrossRefGoogle Scholar
  14. 14.
    Zelkowitz R. Cancer. HPV casts a wider shadow. Science. 2009;323:580–1.PubMedCrossRefGoogle Scholar
  15. 15.
    Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.PubMedCrossRefGoogle Scholar
  16. 16.
    Pincock S. Francoise Barre-Sinoussi: shares Nobel Prize for discovery of HIV. Lancet. 2008;372:1377.PubMedCrossRefGoogle Scholar
  17. 17.
    Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–131.PubMedCrossRefGoogle Scholar
  20. 20.
    Raoult D. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis. 2008;27:631–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Raoult D. Human microbiome: take-home lesson on growth promoters? Nature. 2008;454:690–1.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Unité des RickettsiesFaculté de Médecine, URMITE CNRS-IRD 6236MarseilleFrance

Personalised recommendations